Apellis Pharmaceuticals (NASDAQ:APLS) First Quarter 2024 Results Key Financial Results Revenue: US$172.3m (up 284% from 1Q 2023). Net loss: US$66.4m (loss narrowed by 63% from 1Q 2023). US$0.54 loss ...
Source LinkApellis Pharmaceuticals (NASDAQ:APLS) First Quarter 2024 Results Key Financial Results Revenue: US$172.3m (up 284% from 1Q 2023). Net loss: US$66.4m (loss narrowed by 63% from 1Q 2023). US$0.54 loss ...
Source Link
Comments